Biosimilars of Monoclonal Antibody Market Report

Global and China Biosimilars of Monoclonal Antibody Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 19, 2022
  • PAGES：196
  • REPORT CODE：GMM1477413
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Biosimilars of Monoclonal Antibody industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Roche

    • Eli Lilly

    • Merck

    • Bayer

    • Novo Nordisk

    • Johnson & Johnson

    • Sanofi-Aventis

    • Amgen

    • Pfizer

    • GSK

    • BMS

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Type 1

    • Type 2

    • Type 3

    Application:

    • Application 1

    • Application 2

    • Application 3

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Biosimilars of Monoclonal Antibody Industry Overview

      • 1.1.1 Biosimilars of Monoclonal Antibody Market Scope and Market Segments

      • 1.1.2 Biosimilars of Monoclonal Antibody Industry Characteristics

      • 1.1.3 Global and China Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Biosimilars of Monoclonal Antibody Production Value and Growth Rate (2017-2028)

    • 1.2 Global Biosimilars of Monoclonal Antibody Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Type 1

      • 1.2.2 Type 2

      • 1.2.3 Type 3

    • 1.3 Global Biosimilars of Monoclonal Antibody Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Application 1

      • 1.3.2 Application 2

      • 1.3.3 Application 3

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Biosimilars of Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Biosimilars of Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Biosimilars of Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Biosimilars of Monoclonal Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Biosimilars of Monoclonal Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Biosimilars of Monoclonal Antibody Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Biosimilars of Monoclonal Antibody Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Biosimilars of Monoclonal Antibody Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Biosimilars of Monoclonal Antibody Industry Porter's Five Forces Model Analysis

      • 2.2.3 Biosimilars of Monoclonal Antibody Industry PEST Analysis

    • 2.3 Biosimilars of Monoclonal Antibody Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Biosimilars of Monoclonal Antibody Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Biosimilars of Monoclonal Antibody Industry

    Chapter 3 Global and China Biosimilars of Monoclonal Antibody Market, by Manufacturer

    • 3.1 Global and China Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Biosimilars of Monoclonal Antibody Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Biosimilars of Monoclonal Antibody Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Biosimilars of Monoclonal Antibody Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Biosimilars of Monoclonal Antibody Market Top 3 Players

    Chapter 4 Global and China Biosimilars of Monoclonal Antibody Market, by Type (2017-2028)

    • 4.1 Biosimilars of Monoclonal Antibody Market Trend, by Type

    • 4.2 Global Biosimilars of Monoclonal Antibody Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Biosimilars of Monoclonal Antibody Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Biosimilars of Monoclonal Antibody Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Biosimilars of Monoclonal Antibody Price Trend, by Type (2017-2028)

    • 4.3 China Biosimilars of Monoclonal Antibody Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Biosimilars of Monoclonal Antibody Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Biosimilars of Monoclonal Antibody Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Biosimilars of Monoclonal Antibody Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Biosimilars of Monoclonal Antibody Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Biosimilars of Monoclonal Antibody Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Biosimilars of Monoclonal Antibody Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Biosimilars of Monoclonal Antibody Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Biosimilars of Monoclonal Antibody Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Biosimilars of Monoclonal Antibody Market Analysis

    • 7.1 North America Biosimilars of Monoclonal Antibody Market, by Type

    • 7.2 North America Biosimilars of Monoclonal Antibody Market, by Application

    • 7.3 North America Biosimilars of Monoclonal Antibody Market Analysis and Forecast, by Country

      • 7.3.1 United States Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Biosimilars of Monoclonal Antibody Market Analysis

    • 8.1 Europe Biosimilars of Monoclonal Antibody Market, by Type

    • 8.2 Europe Biosimilars of Monoclonal Antibody Market, by Application

    • 8.3 Europe Biosimilars of Monoclonal Antibody Market Analysis and Forecast, by Country

      • 8.3.1 Germany Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Biosimilars of Monoclonal Antibody Market Analysis

    • 9.1 APAC Biosimilars of Monoclonal Antibody Market, by Type

    • 9.2 APAC Biosimilars of Monoclonal Antibody Market, by Application

    • 9.3 APAC Biosimilars of Monoclonal Antibody Market Analysis and Forecast, by Country

      • 9.3.1 China Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Market Analysis

    • 10.1 Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Market, by Type

    • 10.2 Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Market, by Application

    • 10.3 Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Biosimilars of Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Biosimilars of Monoclonal Antibody Company Profiles

      • 11.1 Roche

        • 11.1.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Roche Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.1.3 Roche Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Eli Lilly

        • 11.2.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Eli Lilly Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.2.3 Eli Lilly Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Merck

        • 11.3.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Merck Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.3.3 Merck Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Bayer

        • 11.4.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Bayer Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.4.3 Bayer Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Novo Nordisk

        • 11.5.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Novo Nordisk Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.5.3 Novo Nordisk Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Johnson & Johnson

        • 11.6.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Johnson & Johnson Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.6.3 Johnson & Johnson Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Sanofi-Aventis

        • 11.7.1 Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Sanofi-Aventis Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.7.3 Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Amgen

        • 11.8.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Amgen Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.8.3 Amgen Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Pfizer

        • 11.9.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Pfizer Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.9.3 Pfizer Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 GSK

        • 11.10.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 GSK Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.10.3 GSK Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 BMS

        • 11.11.1 BMS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 BMS Biosimilars of Monoclonal Antibody Product Profiles, Application and Specification

        • 11.11.3 BMS Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Biosimilars of Monoclonal Antibody Industry Investment Prospect and Risk Assessment

    • 12.1 Biosimilars of Monoclonal Antibody Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Biosimilars of Monoclonal Antibody Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Production Value and Growth Rate (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Production Value and Growth Rate (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Market Size and Growth Rate of Type 1 (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Market Size and Growth Rate of Type 2 (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Market Size and Growth Rate of Type 3 (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Market Size and Growth Rate of Application 1 (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Market Size and Growth Rate of Application 2 (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Market Size and Growth Rate of Application 3 (2017-2028)

    • Figure North America Biosimilars of Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Biosimilars of Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Biosimilars of Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Biosimilars of Monoclonal Antibody Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Biosimilars of Monoclonal Antibody Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Biosimilars of Monoclonal Antibody Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Biosimilars of Monoclonal Antibody Market Share, by Manufacturer in 2021

    • Figure Global and China Biosimilars of Monoclonal Antibody Market Share, by Manufacturer in 2022

    • Table Global Biosimilars of Monoclonal Antibody Sales Volume, by Type (2017-2028)

    • Table Global Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Table Global Biosimilars of Monoclonal Antibody Sales Value, by Type (2017-2028)

    • Table Global Biosimilars of Monoclonal Antibody Sales Value Share, by Type (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Price Trend, by Type (2017-2028)

    • Table China Biosimilars of Monoclonal Antibody Sales Volume, by Type (2017-2028)

    • Table China Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Table China Biosimilars of Monoclonal Antibody Sales Value, by Type (2017-2028)

    • Table China Biosimilars of Monoclonal Antibody Sales Value Share, by Type (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Price Trend, by Type (2017-2028)

    • Table Global Biosimilars of Monoclonal Antibody Sales Volume, by Application (2017-2028)

    • Table Global Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Table Global Biosimilars of Monoclonal Antibody Sales Value, by Application (2017-2028)

    • Table Global Biosimilars of Monoclonal Antibody Sales Value Share, by Application (2017-2028)

    • Figure Global Biosimilars of Monoclonal Antibody Sales Value Share, by Application (2017-2028)

    • Table China Biosimilars of Monoclonal Antibody Sales Volume, by Application (2017-2028)

    • Table China Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Table China Biosimilars of Monoclonal Antibody Sales Value, by Application (2017-2028)

    • Table China Biosimilars of Monoclonal Antibody Sales Value Share, by Application (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Sales Value Share, by Application (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • Figure North America Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)

    • Table North America Biosimilars of Monoclonal Antibody Sales Volume, by Type (2017-2028)

    • Table North America Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Figure North America Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Table North America Biosimilars of Monoclonal Antibody Sales Volume, by Application (2017-2028)

    • Table North America Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure North America Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure United States Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure United States Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Canada Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Table Europe Biosimilars of Monoclonal Antibody Sales Volume, by Type (2017-2028)

    • Table Europe Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Figure Europe Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Table Europe Biosimilars of Monoclonal Antibody Sales Volume, by Application (2017-2028)

    • Table Europe Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure Europe Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure Germany Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure UK Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure UK Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure France Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure France Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Italy Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Spain Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Poland Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Russia Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Table APAC Biosimilars of Monoclonal Antibody Sales Volume, by Type (2017-2028)

    • Table APAC Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Figure APAC Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Table APAC Biosimilars of Monoclonal Antibody Sales Volume, by Application (2017-2028)

    • Table APAC Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure APAC Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure China Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Japan Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure India Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure India Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Biosimilars of Monoclonal Antibody Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Biosimilars of Monoclonal Antibody Sales Value and Growth Rate (2017-2028)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk Product Profiles, Application and Specification

    • Table Novo Nordisk Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi-Aventis Product Profiles, Application and Specification

    • Table Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BMS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BMS Product Profiles, Application and Specification

    • Table BMS Biosimilars of Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US